EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 179 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 30 | 0.0% | 0.00% | – |
Q2 2023 | $1 | 0.0% | 30 | 0.0% | 0.00% | – |
Q1 2023 | $1 | 0.0% | 30 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -99.9% | 30 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 30 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | +100.0% | 30 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | -66.7% | 30 | -63.4% | 0.00% | – |
Q3 2020 | $3,000 | -25.0% | 82 | 0.0% | 0.00% | – |
Q2 2020 | $4,000 | 0.0% | 82 | 0.0% | 0.00% | – |
Q1 2020 | $4,000 | -20.0% | 82 | 0.0% | 0.00% | – |
Q4 2019 | $5,000 | 0.0% | 82 | 0.0% | 0.00% | – |
Q3 2019 | $5,000 | 0.0% | 82 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | +25.0% | 82 | 0.0% | 0.00% | – |
Q1 2019 | $4,000 | +33.3% | 82 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -50.0% | 82 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | 0.0% | 82 | 0.0% | 0.00% | – |
Q2 2018 | $6,000 | +50.0% | 82 | 0.0% | 0.00% | – |
Q1 2018 | $4,000 | – | 82 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |